Please Wait.....
Report
COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2026-2034
Market Report I 2026-03-01 I 143 Pages I IMARC Group
The global COPD and asthma devices market size reached USD 49.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 72.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.24% during 2026-2034. The market growth is primarily driven by continual technological advancements in smart inhalers with real-time monitoring capabilities, growing prevalence of respiratory conditions, an enhanced emphasis on personalized treatment options for more accurate drug delivery and increasing demand in emerging markets due to improved healthcare access.
Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.
COPD AND ASTHMA DEVICES MARKET TRENDS:
Increased Focus on Personalized Treatment Options
The shift towards personalized medicine is causing a substantial effect on the COPD and asthma devices market share, as manufacturers focus on offering solutions tailored to individual patient requirements. Customizable inhalers and nebulizers are becoming more prominent, designed to enhance patient comfort and treatment precision. Personalized dosing systems ensure accurate medication delivery, minimizing side effects and augmenting overall treatment effectiveness. Additionally, the rise of biologic therapies targeting specific molecular pathways involved in respiratory conditions, is encouraging the use of specialized and advanced delivery devices. This personalized approach allows for more effective management of chronic respiratory diseases. As demand for these customized solutions grows, the market is expected to expand, reflecting a broader trend towards individualized healthcare in respiratory treatment.
Technological Advancements in Inhaler Design
Ongoing innovations in inhaler technology are leading the market according to the latest COPD and asthma devices market trends, transforming the management of these respiratory conditions. Smart inhalers, equipped with sensors and Bluetooth connectivity, enable real-time monitoring of medication usage and adherence. This advancement allows patients and healthcare providers to track inhalation patterns and adjust treatments for improved disease control. The integration of mobile apps further supports this by offering reminders, symptom tracking, and data sharing with clinicians. As digital health solutions gain wider adoption, the demand for smart inhalers is rising, which is contributing to the overall growth of the COPD and asthma devices market.
Rising Demand in Emerging Markets
The COPD and asthma devices market size is witnessing strong growth in demand from emerging economies. Factors such as rapid urbanization, rising air pollution levels, and higher smoking rates are contributing to the prevalence of respiratory conditions in regions such as Asia-Pacific, Latin America, and the Middle East. Around 1.1 billion individuals over the age of 15 and over smoke, with 80% residing in low and middle income countries (LMICs). Rising smoking rates, especially among adolescents, pose growing health and economic burdens without stricter controls. Governments and healthcare systems in these regions are investing in better diagnostic tools and treatment devices to address the growing burden of COPD and asthma. Additionally, improved access to healthcare and the increasing adoption of portable inhalers and nebulizers are augmenting market growth in these regions, making emerging markets key centres for future expansion.
COPD AND ASTHMA DEVICES MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each sub-segment of the global COPD and asthma devices market report, along with forecasts at the global, regional, and country level from 2026-2034. Our report has categorized the market based on product, indication and distribution channel.
Breakup by Product:
- Inhalers
o Drug Powdered Inhalers (DPIs)
o Metered Dose Inhalers (MDIs)
o Soft Mist Inhalers
- Nebulizers
o Compressor Nebulizers
o Ultrasonic Nebulizers
o Mesh Nebulizers
Breakup by Indication:
- Asthma
- COPD
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospitals
- Online Pharmacies
Breakup by Region:
- North America
o United States
o Canada
- Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
- Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
- Latin America
o Brazil
o Mexico
o Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global COPD and asthma devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:
- Adherium Limited
- Aerogen Ltd
- AptarGroup, Inc.
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Cipla Limited
- GF Health Products, Inc
- GSK plc
- PARI Respiratory Equipment, Inc.
- ResMed
- Teva Pharmaceuticals USA, Inc.
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global COPD and asthma devices market in 2025?
2. What is the expected growth rate of the global COPD and asthma devices market during 2026-2034?
3. What are the key factors driving the global COPD and asthma devices market?
4. What has been the impact of COVID-19 on the global COPD and asthma devices market?
5. What is the breakup of the global COPD and asthma devices market based on the product?
6. What is the breakup of the global COPD and asthma devices market based on the indication?
7. What is the breakup of the global COPD and asthma devices market based on distribution channel?
8. What are the key regions in the global COPD and asthma devices market?
9. Who are the key players/companies in the global COPD and asthma devices market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global COPD and Asthma Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Inhalers
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Drug Powdered Inhalers (DPIs)
6.1.2.2 Metered Dose Inhalers (MDIs)
6.1.2.3 Soft Mist Inhalers
6.1.3 Market Forecast
6.2 Nebulizers
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Compressor Nebulizers
6.2.2.2 Ultrasonic Nebulizers
6.2.2.3 Mesh Nebulizers
6.2.3 Market Forecast
7 Market Breakup by Indication
7.1 Asthma
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 COPD
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Retail Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Adherium Limited
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Aerogen Ltd
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 AptarGroup, Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Boehringer Ingelheim Pharmaceuticals, Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Cipla Limited
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 GF Health Products, Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 GSK plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 PARI Respiratory Equipment, Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 ResMed
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Teva Pharmaceuticals USA, Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2025
Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2025
Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2025
Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2025
Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million USD), 2020 & 2025
Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million USD), 2020 & 2025
Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2025
Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis
Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2025 & 2034
Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million USD), 2026-2034
Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
Table 7: Global: COPD and Asthma Devices Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security